1. Home
  2. SPOK vs SRDX Comparison

SPOK vs SRDX Comparison

Compare SPOK & SRDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPOK
  • SRDX
  • Stock Information
  • Founded
  • SPOK 2004
  • SRDX 1979
  • Country
  • SPOK United States
  • SRDX United States
  • Employees
  • SPOK 419
  • SRDX N/A
  • Industry
  • SPOK Telecommunications Equipment
  • SRDX Medical/Dental Instruments
  • Sector
  • SPOK Telecommunications
  • SRDX Health Care
  • Exchange
  • SPOK Nasdaq
  • SRDX Nasdaq
  • Market Cap
  • SPOK 379.1M
  • SRDX 415.4M
  • IPO Year
  • SPOK 1992
  • SRDX 1998
  • Fundamental
  • Price
  • SPOK $18.41
  • SRDX $37.46
  • Analyst Decision
  • SPOK Hold
  • SRDX Buy
  • Analyst Count
  • SPOK 1
  • SRDX 3
  • Target Price
  • SPOK $15.00
  • SRDX $43.00
  • AVG Volume (30 Days)
  • SPOK 150.4K
  • SRDX 283.5K
  • Earning Date
  • SPOK 07-30-2025
  • SRDX 08-08-2025
  • Dividend Yield
  • SPOK 6.79%
  • SRDX N/A
  • EPS Growth
  • SPOK 10.71
  • SRDX N/A
  • EPS
  • SPOK 0.83
  • SRDX N/A
  • Revenue
  • SPOK $140,742,000.00
  • SRDX $120,801,000.00
  • Revenue This Year
  • SPOK $2.26
  • SRDX N/A
  • Revenue Next Year
  • SPOK $2.54
  • SRDX $3.19
  • P/E Ratio
  • SPOK $22.17
  • SRDX N/A
  • Revenue Growth
  • SPOK 1.79
  • SRDX N/A
  • 52 Week Low
  • SPOK $13.55
  • SRDX $26.00
  • 52 Week High
  • SPOK $19.31
  • SRDX $40.39
  • Technical
  • Relative Strength Index (RSI)
  • SPOK 57.50
  • SRDX 68.26
  • Support Level
  • SPOK $17.93
  • SRDX $36.86
  • Resistance Level
  • SPOK $18.79
  • SRDX $38.10
  • Average True Range (ATR)
  • SPOK 0.51
  • SRDX 1.18
  • MACD
  • SPOK 0.02
  • SRDX 0.05
  • Stochastic Oscillator
  • SPOK 62.03
  • SRDX 73.06

About SPOK Spok Holdings Inc.

Spok Holdings Inc is a provider of healthcare communications. The company delivers clinical communication and collaboration solutions to help protect the health, well-being, and safety of people in the United States and abroad, on a limited basis, in Europe, Canada, Australia, Asia, and the Middle East. The company develops, sells, and supports enterprise-wide systems principally for healthcare and other organizations needing to automate, centralize, and standardize their approach to clinical and critical communications. The company offers its services and products to three market segments: healthcare, government, and large enterprise, with a greater emphasis on the healthcare market segment. Geographically, the company generates the majority of its revenue from the United States.

About SRDX Surmodics Inc.

Surmodics Inc is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The company's reportable segments are; Medical Device and In Vitro Diagnostics. Maximum revenue for the company is derived from its Medical Device segment which is involved in the manufacturing and licensing of performance coatings, including surface modification coating technologies and drug-delivery coating technologies. This segment also manufactures vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. Geographically, the company derives key revenue from its domestic market.

Share on Social Networks: